Breaking News Instant updates and real-time market news.

PRGO

Perrigo

$86.96

-2.205 (-2.47%)

14:13
11/22/16
11/22
14:13
11/22/16
14:13

Rumor: Perrigo moves up on speculation of sell side conference cancellation

PRGO Perrigo
$86.96

-2.205 (-2.47%)

09/13/16
DBAB
09/13/16
NO CHANGE
Target $105
DBAB
Buy
Deutsche agrees with Starboard that Perrigo is undervalued
Deutsche Bank analyst Gregg Gilbert says Starboard Value "has some relevant points" on Perrigo. The analyst agrees that the stock is undervalued and he keeps a Buy rating on the name. There could be "multiple routes to value enhancement from the current price," Gilbert tells investors in a research note after Starboard took an activist position in the name. He has a Buy rating on the shares with a $105 price target.
09/19/16
RBCM
09/19/16
NO CHANGE
RBCM
Perrigo estimated to be worth about $117 per share in break-up, says RBC Capital
After Reuters reported late Friday that Perrigo is exploring a sale of its Tysabri royalties, RBC Capital analyst Randall Stanicky estimates that the company would be worth about $117 per share if it is "broken up and sold." The analyst warns, however, that it's "far from clear":if the company is interested in selling all of its assets. Stanicky says that the stock's risk/reward ratio has improved, but he adds that he does not expect the stock to rise significantly based on the company's fundamentals. The analyst keeps a $92 price target and Sector Perform rating on the stock.
11/10/16
WELS
11/10/16
NO CHANGE
WELS
Market Perform
Perrigo results should ease concerns about debt covenants, says Wells Fargo
Wells Fargo analyst David Maris said the better than expected Q3 report from Perrigo "was the exact type of quarter" the company needed, where it could show that things are not only no longer getting worse but that they are actually getting better. The upside should ease concerns regarding Perrigo's compliance with it debt covenants, said Maris, who keeps a Market Perform rating on the stock and has a $90-$92 price target range for the shares.
11/11/16
BOFA
11/11/16
UPGRADE
Target $54
BOFA
Neutral
Perrigo upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst Sumant Kulkami upgraded Perrigo to Neutral and maintained its price target of $54 csaying the strategic review provides some support. The analyst said Q3 earnings gave him some confidence that the core US Consumer Healthcare segment is steadily performing and the Rx business is on track versus lowered prices. He expects strategic review results in Q1 that could provide downside protection.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.